Singular Wings 


World first non-invasive contineous glucose monitor by using digital biomarker.

Fundraising Status

Pre-A Round

Fundraising Target: 20M

Schedule: Q2 2023

Revenue (USD)

2022: 200K

2023 Target:  6.2M

Competitors

Apple

Dexcom

Abbott

Medtronic

US Objective

Expected Results

Specific Organizations/VCs to Engage

Company Details

Short description

Singular Wings was established on December 29, 2015, with the aim of enhancing global health through the use of "intelligence". Our team is composed of 22 engineers, including three PhD holders and 14 individuals with master's degrees. We have a blend of young, talented individuals and experienced entrepreneurs on our team. Our research is grounded in the fundamental belief that the electrocardiogram (ECG) is among the most crucial vital signs in the human body. We gather ECG data, along with other essential vital signs and environmental data, to build a system that operates on big data, machine learning AI algorithms, and cloud platforms. Our system is intended to address various chronic illnesses over the internet, such as instant alerts for cardiovascular diseases in the case of certain arrhythmias, home testing for obstructive sleep apnea (OSA), and, in the near future, a non-invasive glucose monitoring system (CGM). All of these applications are conducted via the internet, making telemedicine feasible as long as a network connection exists.

Core Technology

Singular wings One Pager.pdf

Team Members

You can meet him in person:

4/26-4/27 Florida Spinoff

5/1-4 SelectUSA Summit (Maryland)

5/5-8 TAcc+ Silicon Valley Spinoff

You can meet her in person:

4/26-4/27 Florida Spinoff

5/1-4 SelectUSA Summit (Maryland)

5/5-8 TAcc+ Silicon Valley Spinoff

Media Exposures